ad image

IssueQ22022

1 / 3
Integrating Cell Line and CMC Development
Cell Line Development

Integrating Cell Line and CMC Development

Stephen Hamilton, Ph.D.; Mike Brem

Wheeler Bio

PAO-06-022-CL-12Sep 02, 2022
Improving the Therapeutic Index of ADCs with a Peptide Linker Technology
ADCS

Improving the Therapeutic Index of ADCs with a Peptide Linker Technology

Philipp Spycher

Araris Biotech AG

PAO-07-022-CL-01Jul 07, 2022
CAR-T Study Shines New Spotlight on Clinical Trials Representation
Column: Clinical Trials

CAR-T Study Shines New Spotlight on Clinical Trials Representation

David Alvaro, Ph.D.

Pharma's Almanac

PAO-06-022--NI-06Jul 02, 2022
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
Column: M&A

Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.

Nigel Walker

Nice Insight

PAO-06-022--NI-12Jun 24, 2022
New Drug Watch: A Validation of the ‘Twincretin’ Approach to Type 2 Diabetes
Column: New Drug Watch

New Drug Watch: A Validation of the ‘Twincretin’ Approach to Type 2 Diabetes

David Alvaro, Ph.D.

Pharma's Almanac

PAO-06-022--NI-08Jun 24, 2022
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Column: Investment

IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?

Danielle Alvarez

Pharma's Almanac

PAO-06-022--NI-02Jun 24, 2022
The Price of Pain: Acknowledging a Crisis and Encouraging an Alternative
Column: Regulatory Spotlight

The Price of Pain: Acknowledging a Crisis and Encouraging an Alternative

David Alvaro, Ph.D.

Pharma's Almanac

PAO-06-022--NI-05Jun 24, 2022
Digital Frontiers: What NFTs Can Do for Pharma
NFTs

Digital Frontiers: What NFTs Can Do for Pharma

Danielle Alvarez

Pharma's Almanac

PAO-06-022--NI-01Jun 24, 2022
Creating a More Resilient Pharmaceutical Supply Chain One Segment at a Time
Column: Supply Chain

Creating a More Resilient Pharmaceutical Supply Chain One Segment at a Time

Tonia Becker

Nice Insight

PAO-06-022--NI-09Jun 24, 2022
Mental Health During a Global Pandemic
Mental Health

Mental Health During a Global Pandemic

Marc Technow

Nice Insight

PAO-06-022--NI-03Jun 24, 2022
10 More Biotechs Making Moves in 2022
Biotechs

10 More Biotechs Making Moves in 2022

David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

PAO-06-022--NI-07Jun 24, 2022
Taking Adoptive Cell Therapies to the Next Level
Cell Therapy

Taking Adoptive Cell Therapies to the Next Level

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-06-022--NI-04Jun 24, 2022
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
Unmet Needs

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Pharma's Almanac

PAO-06-022--RT-01Jun 24, 2022
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Industry Challenges

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Pharma's Almanac

O-06-022--RT-01Jun 24, 2022
Quantum Computing will Transform Drug Discovery, Development, Manufacturing, and Supply Chain Management
Quantum Computing

Quantum Computing will Transform Drug Discovery, Development, Manufacturing, and Supply Chain Management

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-06-022--NI-10Jun 24, 2022
Small Molecule API Market Trends
API

Small Molecule API Market Trends

James Grote

Nice Insight

PAO-06-022--NI-11Jun 24, 2022
Real-World Data and Artificial Intelligence are Transforming Clinical Development
Real-World Data

Real-World Data and Artificial Intelligence are Transforming Clinical Development

Jeff Elton, Ph.D.

ConcertAI

PAO-06-022-CL-09Jun 21, 2022
Accelerating the Development of High-Quality Cell and Gene Therapies with Comprehensive, In-house Analytical Support
Cell and Gene Therapy Analytics

Accelerating the Development of High-Quality Cell and Gene Therapies with Comprehensive, In-house Analytical Support

Hui Chen, Ph.D.

Porton Advanced Solutions

PAO-06-022-CL-07Jun 21, 2022
Staying Agile to Bring Therapies to Patients with Rare Diseases
Rare Diseases

Staying Agile to Bring Therapies to Patients with Rare Diseases

Sheila Frame

Amryt Pharma

PAO-06-022-CL-08Jun 21, 2022
Tuning the Myeloid Compartment with a Best-in-Class CDMO
Immuno-Oncology

Tuning the Myeloid Compartment with a Best-in-Class CDMO

Kiren Khanduga; Alicia Levey, Ph.D.

Pionyr Immunotherapeutics

PAO-06-022-CL-04Jun 06, 2022
1 / 3